[go: up one dir, main page]

NO20055310L - Terapeutisk plaster med polysiloksanmatriks omfattende capsaicin - Google Patents

Terapeutisk plaster med polysiloksanmatriks omfattende capsaicin

Info

Publication number
NO20055310L
NO20055310L NO20055310A NO20055310A NO20055310L NO 20055310 L NO20055310 L NO 20055310L NO 20055310 A NO20055310 A NO 20055310A NO 20055310 A NO20055310 A NO 20055310A NO 20055310 L NO20055310 L NO 20055310L
Authority
NO
Norway
Prior art keywords
capsaicin
therapeutic compound
preparation
disclosed
therapeutic
Prior art date
Application number
NO20055310A
Other languages
English (en)
Other versions
NO337896B1 (no
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO20055310L publication Critical patent/NO20055310L/no
Publication of NO337896B1 publication Critical patent/NO337896B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives et topisk plaster irmeholdende capsaicin eller en capsaicinanalog, fremgangsmåte for fremstilling derav, samt dets anvendelse. Det beskrives således et topisk plaster omfattende et ryggsjikt som er impermeabelt for terapeutisk forbindelse, en selvadherende matriks basert på polysiloksaner og irmeholdende capsaicin eller terapeutiske forbindelser analoge til capsaicin, og en beskyttende film som ^emes før bruk, hvori matriksen irmeholdende flytende reservoar basert på et amfifilisk oppløsningsmiddel, hvori den terapeutiske forbindelse er tilstede i fullstendig oppløst form og konsentrasjonen av den terapeutiske forbindelse i mikroreservoardråpene er under metningskonsenfrasjonen. Det beskrives videre en fremgangsmåte for fremstilling av slike plaster og deres bruk for behandling av neuropatisk smerte.
NO20055310A 2003-04-14 2005-11-10 Terapeutisk plaster inneholdende en oppløst terapeutisk forbindelse, anvendelse derav samt fremgangsmåte for fremstilling av nevnte plaster NO337896B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46263003P 2003-04-14 2003-04-14
PCT/EP2003/012929 WO2004089361A1 (en) 2003-04-14 2003-11-19 Therapeutic patch with polysiloxane matrix comprising capsaicin

Publications (2)

Publication Number Publication Date
NO20055310L true NO20055310L (no) 2005-11-10
NO337896B1 NO337896B1 (no) 2016-07-04

Family

ID=33159857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055310A NO337896B1 (no) 2003-04-14 2005-11-10 Terapeutisk plaster inneholdende en oppløst terapeutisk forbindelse, anvendelse derav samt fremgangsmåte for fremstilling av nevnte plaster

Country Status (23)

Country Link
US (2) US8821920B2 (no)
EP (1) EP1613297B1 (no)
JP (1) JP4943657B2 (no)
KR (1) KR101050672B1 (no)
CN (2) CN100512806C (no)
AT (1) ATE363900T1 (no)
AU (1) AU2003289710B2 (no)
BR (1) BRPI0318250B8 (no)
CA (1) CA2517493C (no)
CY (1) CY1106744T1 (no)
DE (1) DE60314298T2 (no)
DK (1) DK1613297T3 (no)
ES (1) ES2288222T3 (no)
IL (1) IL171249A (no)
MX (1) MXPA05011012A (no)
NO (1) NO337896B1 (no)
NZ (1) NZ541956A (no)
PL (1) PL219512B1 (no)
PT (1) PT1613297E (no)
RU (1) RU2349315C9 (no)
UA (1) UA81665C2 (no)
WO (1) WO2004089361A1 (no)
ZA (1) ZA200506462B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012599B1 (ru) 2003-04-10 2009-10-30 Ньюроджескс, Инк. Способы и композиции для введения агонистов trpv1
DE102004044578A1 (de) 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
BRPI0607461A2 (pt) * 2005-02-14 2009-09-08 Neurogesx Inc dispositivo para liberação de agonistas de trpv1
WO2006105481A1 (en) * 2005-03-30 2006-10-05 Neurogesx, Inc. Low-concentration capsaicin patch and methods for treating neuropathic pain
JP4505644B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シート
JP4505645B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シートの貼付方法
JP4505646B2 (ja) * 2006-02-20 2010-07-21 フジコピアン株式会社 固定シート
JP4505649B2 (ja) * 2006-03-23 2010-07-21 フジコピアン株式会社 固定シート
JP2007284370A (ja) * 2006-04-14 2007-11-01 Alcare Co Ltd 体表面用貼付材
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
EP2155175B1 (en) * 2007-06-08 2014-03-12 Samyang Biopharmaceuticals Corporation Matrix-type transdermal drug delivery system and preparation method thereof
KR101857827B1 (ko) * 2010-06-09 2018-05-14 카오카부시키가이샤 수증기 발생 온열구
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
HK1220384A1 (zh) * 2013-03-14 2017-05-05 Allergan, Inc. 包含比马前列素的局部组合物和利用其刺激毛发生长的方法
DK2810646T3 (en) * 2013-06-04 2016-10-31 Lts Lohmann Therapie Systeme Ag A transdermal
US10046151B2 (en) 2013-07-03 2018-08-14 Lts Lohmann Therapie-Systeme, Ag Transdermal therapeutic system with electronic component
CN104586818A (zh) * 2013-11-01 2015-05-06 北京中卫神农慢性病医学研究院有限公司 辣椒碱微孔久释器材
KR101574760B1 (ko) * 2013-11-13 2015-12-04 주식회사 엘지생활건강 흡수속도를 개선한 마이크로니들 시스템
ES2924899T3 (es) 2014-05-20 2022-10-11 Lts Lohmann Therapie Systeme Ag Sistema de administración transdérmica que contiene rotigotina
CA2948221C (en) 2014-05-20 2022-11-22 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
CN106456567A (zh) 2014-05-20 2017-02-22 Lts勒曼治疗系统股份公司 在经皮递送系统中调节活性剂释放的方法
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
CN104546805A (zh) * 2014-12-15 2015-04-29 刘闯 一种治疗皮肤色斑的药膏贴
EP3266472A1 (en) * 2016-07-08 2018-01-10 Mölnlycke Health Care AB A medical dressing comprising a carrier and a composite material
KR101880442B1 (ko) * 2017-02-02 2018-07-23 대구한의대학교산학협력단 혈압 강하용 패치 조성물
US12383509B2 (en) * 2017-09-04 2025-08-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an emulsifier
BR112022018608A2 (pt) 2020-03-17 2022-11-08 Gruenenthal Gmbh Aplicação tópica repetida de emplastro de capsaicina para o tratamento de não-respondedores iniciais
KR20220164022A (ko) 2020-04-03 2022-12-12 그뤼넨탈 게엠베하 캡사이신 패치의 반복된 국소 적용 요법
TWI807338B (zh) * 2020-06-26 2023-07-01 美商美國禮來大藥廠 結合ＴＧＦ-α及表皮調節素（ＥＰＩＲＥＧＵＬＩＮ）之抗體於治療疼痛之用途
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy
JP7683009B2 (ja) * 2020-12-30 2025-05-26 エルケム・シリコーンズ・シャンハイ・カンパニー・リミテッド カプサイシン含有シリコーンゲルでコーティングされたパッチ
CN120752028A (zh) * 2023-03-15 2025-10-03 Lts罗曼治疗系统股份公司 包含辣椒素的医用贴剂
WO2024189213A1 (en) * 2023-03-15 2024-09-19 Lts Lohmann Therapie-Systeme Ag Medical patch comprising skin irritating active agent
WO2025087915A1 (en) * 2023-10-23 2025-05-01 Lts Lohmann Therapie-Systeme Ag Medical patch comprising capsaicin or a capsaicin analog

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946106A (en) 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US5145682A (en) 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB8704755D0 (en) 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
CN1037242C (zh) * 1994-04-22 1998-02-04 天津轻工业学院 以干红辣椒为原料制备辣椒碱的方法
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
RU2097057C1 (ru) * 1995-11-15 1997-11-27 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав мази болеутоляющего и местнораздражающего действия с тепловым эффектом
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
CA2267049A1 (en) * 1999-02-05 2000-08-05 Bioglan Laboratories Ltd. Pharmaceutical compositions
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
BR0012152A (pt) * 1999-07-02 2002-03-12 Lohmann Therapie Syst Lts Sistema de microrreservatórios na base de polissiloxanos e solventes ambifìlicos
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10114382A1 (de) 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
JP3989188B2 (ja) * 2001-04-27 2007-10-10 クリストファー・エム・キム 蜂針を用いない蜂毒療法
CA2447302C (en) * 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
WO2003015698A2 (en) * 2001-08-13 2003-02-27 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
US7247315B2 (en) * 2001-08-17 2007-07-24 Lavipharm Laboratories Inc. Compositions and medical device for transdermal delivery of a drug and methods of making and using same
US8246979B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine

Also Published As

Publication number Publication date
CN1784222A (zh) 2006-06-07
PL378806A1 (pl) 2006-05-15
DE60314298T2 (de) 2008-01-31
BR0318250A (pt) 2006-05-23
MXPA05011012A (es) 2005-12-12
BRPI0318250B8 (pt) 2021-05-25
BRPI0318250B1 (pt) 2015-08-11
KR20060002997A (ko) 2006-01-09
WO2004089361A1 (en) 2004-10-21
HK1136957A1 (en) 2010-07-16
ATE363900T1 (de) 2007-06-15
EP1613297A1 (en) 2006-01-11
RU2349315C9 (ru) 2010-02-27
ES2288222T3 (es) 2008-01-01
DK1613297T3 (da) 2007-09-24
PT1613297E (pt) 2007-08-23
DE60314298D1 (de) 2007-07-19
CY1106744T1 (el) 2012-05-23
CA2517493A1 (en) 2004-10-21
RU2349315C2 (ru) 2009-03-20
JP4943657B2 (ja) 2012-05-30
NO337896B1 (no) 2016-07-04
RU2005134984A (ru) 2007-05-27
CN101601664A (zh) 2009-12-16
CN100512806C (zh) 2009-07-15
NZ541956A (en) 2008-09-26
AU2003289710B2 (en) 2009-07-30
HK1090844A1 (zh) 2007-01-05
CA2517493C (en) 2011-05-31
ZA200506462B (en) 2006-05-31
UA81665C2 (ru) 2008-01-25
EP1613297B1 (en) 2007-06-06
US20040202707A1 (en) 2004-10-14
US8821920B2 (en) 2014-09-02
KR101050672B1 (ko) 2011-07-19
CN101601664B (zh) 2012-05-23
IL171249A (en) 2010-06-16
AU2003289710A1 (en) 2004-11-01
PL219512B1 (pl) 2015-05-29
JP2006514977A (ja) 2006-05-18
US20140335150A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
NO20055310L (no) Terapeutisk plaster med polysiloksanmatriks omfattende capsaicin
WO2007008257A3 (en) Method and apparatus for delivering epinephrine
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BRPI0414146A (pt) aparelho para o controle da glicose no sangue
RU2009123368A (ru) Трансдермальная терапевтическая система для введения активного вещества бупренорфина
NO20063171L (no) Endoparasitisidale sammensetninger for topisk anvendelse
BRPI0515061B8 (pt) dispositivo de infusão e método para reduzir a formação de bolhas na reconstituição de uma fórmula
NO884679D0 (no) Beskyttende overflatebehandling.
BR0114628A (pt) Membro de retenção em microprojeção para aplicador de impacto
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ATE509617T1 (de) Phenytoinformulierungen und ihre verwendungen in der wundheilung
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
BR0208005A (pt) Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo
WO2009070739A3 (en) Systems, devices, and methods for directly energizing water molecule composition
EE200100250A (et) Meetod vaikusisaldava puitsubstraadi immutus või ekstraheerimistöötluseks
BR112014017141A2 (pt) método de tratamento de diabetes usando-se apolipoproteína a-iv não glicosilada
ATE422877T1 (de) Zusammensetzungen zur haarbehandlung
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
PL378076A1 (pl) Transdermalny system terapeutyczny nadający się do użycia ciepła w celu przyspieszenia przenikania substancji czynnych i jego zastosowanie
ATE501710T1 (de) Somatostatin-analog-formulierungen
WO2009007334A3 (de) Transdermale therapeutische systeme, welche den wirkstoff anastrozol enthalten
AR025391A1 (es) Procedimiento para aplicar a chorro un preparado en fase liquida que contenga un principio activo sobre un sustrato plano
DE60335892D1 (de) Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung und/oder fettleibigkeit im zusammenhang steht
DE20221247U1 (de) Transdermal-Pflaster zum Verabreichen von Fentanyl
ATE454897T1 (de) Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation

Legal Events

Date Code Title Description
MK1K Patent expired